Found: 14
Select item for more details and to access through your institution.
SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. 643, doi. 10.1016/j.clml.2022.03.008
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Beyond BCL-2 Inhibition in Acute Myeloid Leukemia: Other Approaches to Leverage the Apoptotic Pathway.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. 652, doi. 10.1016/j.clml.2022.04.001
- By:
- Publication type:
- Article
Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. 659, doi. 10.1016/j.clml.2022.04.015
- By:
- Publication type:
- Article
The Path Forward in Multiple Myeloma: 2021 Jan Waldenstrom Award Lecture.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. 666, doi. 10.1016/j.clml.2022.04.021
- By:
- Publication type:
- Article
Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. 670, doi. 10.1016/j.clml.2022.04.016
- By:
- Publication type:
- Article
Peripheral Blood Involvement at Staging in Patients With Aggressive Peripheral T-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. 680, doi. 10.1016/j.clml.2022.04.019
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. 690, doi. 10.1016/j.clml.2022.04.025
- By:
- Publication type:
- Article
Long-Term Complete Clinical and Hematological Response With Bortezomib: The Report of a Case With TEM(P)I Syndrome and a Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. 702, doi. 10.1016/j.clml.2022.04.018
- By:
- Publication type:
- Article
Multiple Myeloma: Impact of Time to Transplant on the Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e826, doi. 10.1016/j.clml.2022.04.020
- By:
- Publication type:
- Article
Time to First Subsequent Salvage Therapy in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin in the Phase III INO-VATE Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e836, doi. 10.1016/j.clml.2022.04.022
- By:
- Publication type:
- Article
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e844, doi. 10.1016/j.clml.2022.04.024
- By:
- Publication type:
- Article
Patient Preferences for Benefits, Risks, and Administration Route of Hypomethylating Agents in Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e853, doi. 10.1016/j.clml.2022.04.023
- By:
- Publication type:
- Article
Efficacy and Safety of Generic Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Multicenter Prospective Study in China.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e867, doi. 10.1016/j.clml.2022.05.002
- By:
- Publication type:
- Article
Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e874, doi. 10.1016/j.clml.2022.05.001
- By:
- Publication type:
- Article